Growth Hormone Deficiency Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932363

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932363

Table of Contents
Description

The global Growth Hormone Deficiency market was valued at $3.13 billion in 2020 and is projected to reach $5.80 billion by 2028, growing at a CAGR of 7.99% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including a rise in cases of endocrine diseases, which serve as a primary driving factor for the market.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Brands (Genotropin, Norditropin, Humatrope, Saizen, Omnitrope, Others)
By Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral, Others)
By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites, Others, )

Key players

Novo Nordisk A/S
Pfizer Inc
Novartis AG
Anhui Anke Biotechnology (Group) Co., Ltd
Biopartners GmbH
Ipsen S.A.
Eli Lily And Company
Merck KGaA
GeneScience Pharmaceuticals Co., Ltd
Lifetech Labs

Chapter 1. Executive Summary
Chapter 2. Scope of The Study: 2.1. Market Definition; 2.2. Scope of The Study; 2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends: 4.1. Supply/ Value Chain Analysis; 4.2. Porter’s Five Forces Analysis; 4.2.1. Threat of New Entrants; 4.2.2. Bargaining Power of Buyers; 4.2.3. Bargaining Power of Suppliers; 4.2.4. Threat of Substitutes; 4.2.5. Industry Rivalry; 4.3. Impact of COVID-19 on Growth Hormone Deficiency Market; 4.3.1. Impact on Market Size; 4.3.2. Distribution Channel Trend, Preferences and Budget Impact; 4.3.3. Regulatory Framework/Government Policies; 4.3.4. Key Players Strategy to Tackle Negative Impact; 4.3.5. Opportunity Window
Chapter 5. Market Dynamics: 5.1. Introduction; 5.2. DRO Analysis; 5.2.1. Drivers; 5.2.2. Restraints; 5.2.3. Opportunities
Chapter 6. Global Growth Hormone Deficiency Market, By Brands: 6.1. Introduction; 6.2. Genotropin; 6.3. Norditropin; 6.4. Humatrope; 6.5. Saizen; 6.6. Omnitrope; 6.7. Others
Chapter 7. Global Growth Hormone Deficiency Market, By Route of Administration: 7.1. Introduction; 7.2. Subcutaneous; 7.3. Intramuscular; 7.4. Intravenous; 7.5. Oral; 7.6. Others
Chapter 8. Global Growth Hormone Deficiency Market, By Application: 8.1. Introduction; 8.2. Growth Hormone Deficiency; 8.3. Idiopathic Short Stature; 8.4. Small for Gestational Age; 8.5. Turner Syndrome; 8.6. Prader-Willi Syndrome; 8.7. Others
Chapter 9. Global Growth Hormone Deficiency Market, By Distribution Channel: 9.1. Introduction; 9.2. Hospital Pharmacies; 9.3. Retail Pharmacies; 9.4. Clinics; 9.5. E-Commerce Websites; 9.6. Others
Chapter 10. Global Growth Hormone Deficiency Market, By Region: 10.1. Introduction; 10.2. North America; 10.2.1. Introduction; 10.2.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.3. Market Size and Forecast, By Country, 2020 - 2028; 10.2.4. Market Size and Forecast, By Brands, 2020 - 2028; 10.2.5. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.2.6. Market Size and Forecast, By Application, 2020 – 2028; 10.2.7. Market Size and Forecast, By Distribution Channel, 2020 – 2028; 10.2.8. US; 10.2.8.1. Introduction; 10.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.8.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.2.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.2.8.5. Market Size and Forecast, By Application, 2020 – 2028; 10.2.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.2.9. Canada; 10.2.9.1. Introduction; 10.2.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.9.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.2.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.2.9.5. Market Size and Forecast, By Application, 2020 – 2028; 10.2.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.3. Market Size and Forecast, By Country, 2020 - 2028; 10.3.4. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.5. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.6. Market Size and Forecast, By Application, 2020 – 2028; 10.3.7. Market Size and Forecast, By Distribution Channel, 2020 – 2028; 10.3.8. Germany; 10.3.8.1. Introduction; 10.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.8.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.8.5. Market Size and Forecast, By Application, 2020 – 2028; 10.3.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.3.9. France; 10.3.9.1. Introduction; 10.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.9.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.9.5. Market Size and Forecast, By Application, 2020 – 2028; 10.3.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.3.10. UK; 10.3.10.1. Introduction; 10.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.10.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.10.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.10.5. Market Size and Forecast, By Application, 2020 – 2028; 10.3.10.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.3.11. Italy; 10.3.11.1. Introduction; 10.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.11.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.11.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.11.5. Market Size and Forecast, By Application, 2020 – 2028; 10.3.11.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.3.12. Rest of Europe; 10.3.12.1. Introduction; 10.3.12.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.12.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.3.12.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.3.12.5. Market Size and Forecast, By Application, 2020 – 2028; 10.3.12.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4. Asia-Pacific; 10.4.1. Introduction; 10.4.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.3. Market Size and Forecast, By Country, 2020 - 2028; 10.4.4. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.5. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.6. Market Size and Forecast, By Application, 2020 – 2028; 10.4.7. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4.8. China; 10.4.8.1. Introduction; 10.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.8.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.8.5. Market Size and Forecast, By Application, 2020 – 2028; 10.4.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4.9. India; 10.4.9.1. Introduction; 10.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.9.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.9.5. Market Size and Forecast, By Application, 2020 – 2028; 10.4.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4.10. Japan; 10.4.10.1. Introduction; 10.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.10.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.10.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.10.5. Market Size and Forecast, By Application, 2020 – 2028; 10.4.10.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4.11. South Korea; 10.4.11.1. Introduction; 10.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.11.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.11.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.11.5. Market Size and Forecast, By Application, 2020 – 2028; 10.4.11.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.4.12. Rest of Asia-Pacific; 10.4.12.1. Introduction; 10.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.12.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.4.12.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.4.12.5. Market Size and Forecast, By Application, 2020 – 2028; 10.4.12.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.5. Rest of The World (RoW); 10.5.1. Introduction; 10.5.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.5.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.5.5. Market Size and Forecast, By Application, 2020 – 2028; 10.5.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.5.7. Market Size and Forecast, By Region, 2020 - 2028; 10.5.8. South America; 10.5.8.1. Introduction; 10.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.8.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.5.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.5.8.5. Market Size and Forecast, By Application, 2020 – 2028; 10.5.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028; 10.5.9. Middle East & Africa; 10.5.9.1. Introduction; 10.5.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.9.3. Market Size and Forecast, By Brands, 2020 - 2028; 10.5.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028; 10.5.9.5. Market Size and Forecast, By Application, 2020 – 2028; 10.5.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
Chapter 11. Competitive Landscape: 11.1. Introduction; 11.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 12. Company Profiles: 12.1. Novo Nordisk A/S; 12.1.1. Business Overview; 12.1.2. Financial Analysis; 12.1.3. Product Portfolio; 12.1.4. Recent Development and Strategies Adopted; 12.1.5. SWOT Analysis; 12.2. Pfizer Inc; 12.2.1. Business Overview; 12.2.2. Financial Analysis; 12.2.3. Product Portfolio; 12.2.4. Recent Development and Strategies Adopted; 12.2.5. SWOT Analysis; 12.3. Novartis AG; 12.3.1. Business Overview; 12.3.2. Financial Analysis; 12.3.3. Product Portfolio; 12.3.4. Recent Development and Strategies Adopted; 12.3.5. SWOT Analysis; 12.4. Anhui Anke Biotechnology (Group) Co., Ltd; 12.4.1. Business Overview; 12.4.2. Financial Analysis; 12.4.3. Product Portfolio; 12.4.4. Recent Development and Strategies Adopted; 12.4.5. SWOT Analysis; 12.5. Biopartners GmbH; 12.5.1. Business Overview; 12.5.2. Financial Analysis; 12.5.3. Product Portfolio; 12.5.4. Recent Development and Strategies Adopted; 12.5.5. SWOT Analysis; 12.6. Ipsen S.A.; 12.6.1. Business Overview; 12.6.2. Financial Analysis; 12.6.3. Product Portfolio; 12.6.4. Recent Development and Strategies Adopted; 12.6.5. SWOT Analysis; 12.7. Eli Lily And Company; 12.7.1. Business Overview; 12.7.2. Financial Analysis; 12.7.3. Product Portfolio; 12.7.4. Recent Development and Strategies Adopted; 12.7.5. SWOT Analysis; 12.8. Merck KGaA; 12.8.1. Business Overview; 12.8.2. Financial Analysis; 12.8.3. Product Portfolio; 12.8.4. Recent Development and Strategies Adopted; 12.8.5. SWOT Analysis; 12.9. GeneScience Pharmaceuticals Co., Ltd; 12.9.1. Business Overview; 12.9.2. Financial Analysis; 12.9.3. Product Portfolio; 12.9.4. Recent Development and Strategies Adopted; 12.9.5. SWOT Analysis; 12.10. Lifetech Labs; 12.10.1. Business Overview; 12.10.2. Financial Analysis; 12.10.3. Product Portfolio; 12.10.4. Recent Development and Strategies Adopted; 12.10.5. SWOT Analysis
Chapter 13. Key Takeaways